<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Cyclophosphamide</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Cyclophosphamide">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Cyclophosphamide</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Cyclophosphamide</b> (<b>CP</b>), also known as <b>cytophosphane</b> among other names,<span class="mw-ref" id="cite_ref-3"><a href="#cite_note-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> is a medication used as chemotherapy and to suppress the immune system.<span class="mw-ref" id="cite_ref-AHFS2016_4-0"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma.<span class="mw-ref" id="cite_ref-AHFS2016_4-1"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> As an immune suppressor it is used in nephrotic syndrome, granulomatosis with polyangiitis, and following organ transplant, among other conditions.<span class="mw-ref" id="cite_ref-AHFS2016_4-2"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Pagnoux_5-0"><a href="#cite_note-Pagnoux-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> It is taken by mouth or injection into a vein.<span class="mw-ref" id="cite_ref-AHFS2016_4-3"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p> 
 


<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Cyclophosphamide</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Cyclophosphamide.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Cyclophosphamide.svg.png" data-file-width="512" data-file-height="657" data-file-type="drawing" height="160" width="125"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/R-cyclophosphamide-from-xtal-1996-3D-balls.png" tppabs="https://ptable.com/wiki/compounds/I/m/R-cyclophosphamide-from-xtal-1996-3D-balls.png" data-file-width="1378" data-file-height="2000" data-file-type="bitmap" height="181" width="125"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pronunciation</th><td><span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt">/<span style="border-bottom:1px dotted"><span>ˌ</span><span>s</span><span>aɪ</span><span>k</span><span>l</span><span>oʊ</span><span>ˈ</span><span>f</span><span>ɒ</span><span>s</span><span>f</span><span>ə</span><span>ˌ</span><span>m</span><span>aɪ</span><span>d</span></span>,<span class="wrap"> </span>-<span style="border-bottom:1px dotted"><span>l</span><span>ə</span></span>-/</span></span><span class="mw-ref" id="cite_ref-1"><a href="#cite_note-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-2"><a href="#cite_note-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span> </span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Lyophilized Cytoxan, Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cycloblastin</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/cyclophosphamide.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/cyclophosphamide.html'" tppabs="https://www.drugs.com/monograph/cyclophosphamide.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a682080.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a682080.html'" tppabs="https://medlineplus.gov/druginfo/meds/a682080.html" class="external text external">a682080</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>D<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>D (Evidence of risk)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth, by injection into a vein</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>L01AA01<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=L01AA01  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=L01AA01'" tppabs="https://www.whocc.no/atc_ddd_index/?code=L01AA01" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">CA</abbr></small>:<span> </span> ℞-only<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li>
<li>In<span>&nbsp;</span>general: ℞<span>&nbsp;</span>(Prescription only)</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>&gt;75% (by mouth)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>&gt;60%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>3–12 hours</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Kidney</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(<i>RS</i>)-<i>N</i>,<i>N</i>-bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=50-18-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=50-18-0'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=50-18-0" class="external text external">50-18-0</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/2907  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/2907'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/2907" class="external text external">2907</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00531  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00531'" tppabs="https://www.drugbank.ca/drugs/DB00531" class="external text external">DB00531</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.2804.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.2804.html'" tppabs="http://www.chemspider.com/Chemical-Structure.2804.html" class="external text external">2804</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=6UXW23996M  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=6UXW23996M'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=6UXW23996M" class="external text external">6UXW23996M</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D07760  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D07760'" tppabs="https://www.kegg.jp/entry/D07760" class="external text external">D07760</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:4027  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:4027'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:4027" class="external text external">CHEBI:4027</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL88  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL88'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL88" class="external text external">ChEMBL88</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID5020364  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID5020364'" tppabs="https://comptox.epa.gov/dashboard/DTXSID5020364" class="external text external">DTXSID5020364</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.000.015  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.000.015'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.000.015" class="external text external">100.000.015</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>7</sub><span>H</span><sub>15</sub><span>Cl</span><sub>2</sub><span>N</span><sub>2</sub><span>O</span><sub>2</sub><span>P</span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">261.08</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DP1%28OCCCN1%29N%28CCCl%29CCCl  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DP1%28OCCCN1%29N%28CCCl%29CCCl'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DP1%28OCCCN1%29N%28CCCl%29CCCl" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Melting point</th><td>2<span>&nbsp;</span>°C (36<span>&nbsp;</span>°F)</td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=P1(OCCCN1)N(CCCl)CCCl</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:CMSMOCZEIVJLDB-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=459435450&page2=Cyclophosphamide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=459435450&page2=Cyclophosphamide'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=459435450&page2=Cyclophosphamide" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Most people develop side effects.<span class="mw-ref" id="cite_ref-AHFS2016_4-4"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Common side effects include low white blood cell counts, loss of appetite, vomiting, hair loss, and bleeding from the bladder.<span class="mw-ref" id="cite_ref-AHFS2016_4-5"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Other severe side effects include an increased future risk of cancer, infertility, allergic reactions, and pulmonary fibrosis.<span class="mw-ref" id="cite_ref-AHFS2016_4-6"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Cyclophosphamide is in the alkylating agent and nitrogen mustard family of medications.<span class="mw-ref" id="cite_ref-AHFS2016_4-7"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It is believed to work by interfering with the duplication of DNA and the creation of RNA.<span class="mw-ref" id="cite_ref-AHFS2016_4-8"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


<p>Cyclophosphamide was approved for medical use in the United States in 1959.<span class="mw-ref" id="cite_ref-AHFS2016_4-9"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It is on the World Health Organization's List of Essential Medicines.<span class="mw-ref" id="cite_ref-WHO21st_6-0"><a href="#cite_note-WHO21st-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>Cyclophosphamide is used to treat cancers and autoimmune diseases. It is used to quickly control the disease. Due to its toxicity, it is replaced as soon as possible by less toxic drugs. Regular and frequent laboratory evaluations are required to monitor kidney function, avoid drug-induced bladder complications and screen for bone marrow toxicity.</p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Cancer">Cancer</h3></summary>
    
<div class="thumb tleft"><div class="thumbinner" style="width:152px"><img src="../I/m/Cyclophosphamide_iv.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Cyclophosphamide_iv.jpg" data-file-width="1800" data-file-height="2700" data-file-type="bitmap" height="225" width="150"><div class="thumbcaption" style="text-align: left">Cyclophosphamide IV drip</div></div></div>
<p>The main use of cyclophosphamide is with other chemotherapy agents in the treatment of lymphomas, some forms of brain cancer, neuroblastoma, leukemia and some solid tumors.<span class="mw-ref" id="cite_ref-MD_7-0"><a href="#cite_note-MD-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Autoimmune_diseases">Autoimmune diseases</h3></summary>
    
<p>Cyclophosphamide decreases the immune system's response, and although concerns about toxicity restrict its use to patients with severe disease, it remains an important treatment for life-threatening autoimmune diseases where disease-modifying antirheumatic drugs (DMARDs) have been ineffective.   For example, systemic lupus erythematosus with severe lupus nephritis may respond to pulsed cyclophosphamide. Cyclophosphamide is also used to treat minimal change disease,<span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> severe rheumatoid arthritis, granulomatosis with polyangiitis,<span class="mw-ref" id="cite_ref-Pagnoux_5-1"><a href="#cite_note-Pagnoux-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Goodpasture syndrome<span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> and multiple sclerosis.<span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>

<p>Because of its potential side effects, cyclophosphamide is used for early phases of treatment and later substituted by other medications, such as <a href="Mycophenolic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Mycophenolic_acid" title="Mycophenolic acid">mycophenolic acid</a> or ACA.<span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="AL_amyloidosis">AL amyloidosis</h3></summary>
    
<p>Cyclophosphamide, used in combination with <a href="Thalidomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Thalidomide" title="Thalidomide">thalidomide</a> or <a href="Lenalidomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lenalidomide" title="Lenalidomide">lenalidomide</a> and <a href="Dexamethasone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexamethasone" title="Dexamethasone">dexamethasone</a> has documented efficacy as an off-label treatment of AL amyloidosis. It appears to be an alternative to the more traditional treatment with <a href="Melphalan.htm" tppabs="https://ptable.com/wiki/compounds/A/Melphalan" title="Melphalan">melphalan</a> in people who are ill-suited for autologous stem cell transplant.<span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-MD_7-1"><a href="#cite_note-MD-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Graft-versus-host_disease">Graft-versus-host disease</h3></summary>
    
<p>Graft-versus-host disease (GVHD) is a major barrier for allogeneic stem cell transplant because of the immune reactions of donor T cell against the person receiving them. GVHD can often be avoided by T-cell depletion of the graft.<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> The use of a high dose cyclophosphamide post-transplant in a half matched or haploidentical donor hematopoietic stem cell transplantation reduces GVHD, even after using a reduced conditioning regimen.<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    
<p>Like other alkylating agents, cyclophosphamide is teratogenic and contraindicated in pregnant women (pregnancy category D) except for life-threatening circumstances in the mother. Additional relative contraindications to the use of cyclophosphamide include lactation, active infection, neutropenia or bladder toxicity.<span class="mw-ref" id="cite_ref-MD_7-2"><a href="#cite_note-MD-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>

<p>Cyclophosphamide is a pregnancy category D drug and causes birth defects. First trimester exposure to cyclophosphamide for the treatment of cancer or lupus displays a pattern of anomalies labeled "cyclophosphamide embryopathy," including growth restriction, ear and facial abnormalities, absence of digits and hypoplastic limbs.<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>Adverse drug reactions from cyclophosphamide are related to the cumulative medication dose and include chemotherapy-induced nausea and vomiting,<span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> bone marrow suppression,<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> stomach ache, hemorrhagic cystitis, diarrhea, darkening of the skin/nails, alopecia (hair loss) or thinning of hair, changes in color and texture of the hair, lethargy, and profound gonadotoxicity. Other side effects may include easy bruising/bleeding, joint pain, mouth sores, slow-healing existing wounds, unusual decrease in the amount of urine or unusual tiredness or weakness. Potential side effects also include leukopenia, infection, bladder toxicity, and cancer.<span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>

<p>Pulmonary injury appears rare,<span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> but can present with two clinical patterns: an early, acute pneumonitis and a chronic, progressive fibrosis.<span class="mw-ref" id="cite_ref-21"><a href="#cite_note-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> Cardiotoxicity is a major problem with people treated with higher dose regimens.<span class="mw-ref" id="cite_ref-22"><a href="#cite_note-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span></p>

<p>High-dose intravenous cyclophosphamide can cause the syndrome of inappropriate antidiuretic hormone secretion (SIADH) and a potentially fatal hyponatremia when compounded by intravenous fluids administered to prevent drug-induced cystitis.<span class="mw-ref" id="cite_ref-23"><a href="#cite_note-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> While SIADH has been described primarily with higher doses of cyclophosphamide, it can also occur with the lower doses used in the management of inflammatory disorders.<span class="mw-ref" id="cite_ref-24"><a href="#cite_note-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Bladder_bleeding">Bladder bleeding</h3></summary>
    
<p><a href="Acrolein.htm" tppabs="https://ptable.com/wiki/compounds/A/Acrolein" title="Acrolein">Acrolein</a> is toxic to the bladder epithelium and can lead to hemorrhagic cystitis, which is associated with microscopic or gross hematuria and occasionally dysuria.<span class="mw-ref" id="cite_ref-pmid19786984_25-0"><a href="#cite_note-pmid19786984-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> Risks of hemorrhagic cystitis can be minimized with adequate fluid intake, avoidance of nighttime dosage and mesna (sodium 2-mercaptoethane sulfonate), a sulfhydryl donor which binds and detoxifies acrolein.<span class="mw-ref" id="cite_ref-26"><a href="#cite_note-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> Intermittent dosing of cyclophosphamide decreases cumulative drug dose, reduces bladder exposure to acrolein and has equal efficacy to daily treatment in the management of lupus nephritis.<span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Infection">Infection</h3></summary>
    
<p>Neutropenia or lymphopenia arising secondary to cyclophosphamide usage can predispose people to a variety of bacterial, fungal and opportunistic infections.<span class="mw-ref" id="cite_ref-28"><a href="#cite_note-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> No published guidelines cover PCP prophylaxis for people with rheumatological diseases receiving immunosuppressive drugs, but some advocate its use when receiving high-dose medication.<span class="mw-ref" id="cite_ref-29"><a href="#cite_note-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-Kronbichler2015_30-0"><a href="#cite_note-Kronbichler2015-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Infertility">Infertility</h3></summary>
    
<p>Cyclophosphamide has been found to significantly increase the risk of premature menopause in females and of infertility in males and females, the likelihood of which increases with cumulative drug dose and increasing patient age. Such infertility is usually temporary, but can be permanent.<span class="mw-ref" id="cite_ref-31"><a href="#cite_note-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> The use of <a href="Leuprorelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Leuprorelin" title="Leuprorelin">leuprorelin</a> in women of reproductive age before administration of intermittently dosed cyclophosphamide may diminish the risks of premature menopause and infertility.<span class="mw-ref" id="cite_ref-32"><a href="#cite_note-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Cancer_2">Cancer</h3></summary>
    
<p>Cyclophosphamide is carcinogenic and may increase the risk of developing lymphomas, leukemia, skin cancer, transitional cell carcinoma of the bladder or other malignancies.<span class="mw-ref" id="cite_ref-33"><a href="#cite_note-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span> Myeloproliferative neoplasms, including acute leukemia, non-Hodgkin lymphoma and multiple myeloma, occurred in 5 of 119 rheumatoid arthritis patients within the first decade after receiving cyclophosphamide, compared with one case of chronic lymphocytic leukemia in 119 rheumatoid arthritis patients with no history.<span class="mw-ref" id="cite_ref-34"><a href="#cite_note-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span> Secondary acute myeloid leukemia (therapy-related AML, or "t-AML") is thought to occur either by cyclophosphamide-inducing mutations or selecting for a high-risk myeloid clone.<span class="mw-ref" id="cite_ref-35"><a href="#cite_note-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span></p>

<p>This risk may be dependent on dose and other factors, including the condition, other agents or treatment modalities (including radiotherapy), treatment length and intensity. For some regimens, it is rare. For instance, CMF-therapy for breast cancer (where the cumulative dose is typically less than 20<span>&nbsp;</span>grams of cyclophosphamide) carries an AML risk of less than 1/2000, with some studies finding no increased risk compared to background. Other treatment regimens involving higher doses may carry risks of 1–2% or higher. Cyclophosphamide-induced AML, when it happens, typically presents some years after treatment, with incidence peaking around 3–9 years. After nine years, the risk falls to background. When AML occurs, it is often preceded by a myelodysplastic syndrome phase, before developing into overt acute leukemia. Cyclophosphamide-induced leukemia will often involve complex cytogenetics, which carries a worse prognosis than <i>de novo</i> AML.</p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    
<p>Oral cyclophosphamide is rapidly absorbed and then converted by mixed-function oxidase enzymes (cytochrome P450 system) in the liver to active metabolites.<span class="mw-ref" id="cite_ref-pmid4393764_36-0"><a href="#cite_note-pmid4393764-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span><span class="mw-ref" id="cite_ref-37"><a href="#cite_note-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span> The main active metabolite is 4-hydroxycyclophosphamide, which exists in equilibrium with its tautomer, <a href="Cyclophosphamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Aldophosphamide" title="Aldophosphamide" class="mw-redirect">aldophosphamide</a>. Most of the aldophosphamide is then oxidised by the enzyme aldehyde dehydrogenase (ALDH) to make carboxycyclophosphamide. A small proportion of aldophosphamide freely diffuses into cells, where it is decomposed into two compounds, phosphoramide mustard and acrolein.<span class="mw-ref" id="cite_ref-pmid10803453_38-0"><a href="#cite_note-pmid10803453-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> The active metabolites of cyclophosphamide are highly protein bound and distributed to all tissues, are assumed to cross the placenta and are known to be present in breast milk.<span class="mw-ref" id="cite_ref-39"><a href="#cite_note-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span></p>

<p>It is specifically in the oxazaphosphorine group of medications.<span class="mw-ref" id="cite_ref-pmid_20446865_40-0"><a href="#cite_note-pmid_20446865-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span></p>
 
<p>Cyclophosphamide metabolites are primarily excreted in the urine unchanged, and drug dosing should be appropriately adjusted in the setting of renal dysfunction.<span class="mw-ref" id="cite_ref-41"><a href="#cite_note-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span> Drugs altering hepatic microsomal enzyme activity (e.g., <a href="Ethanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethanol" title="Ethanol">alcohol</a>, <a href="Barbiturate.htm" tppabs="https://ptable.com/wiki/compounds/A/Barbiturates" title="Barbiturates" class="mw-redirect">barbiturates</a>, <a href="Rifampicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rifampicin" title="Rifampicin">rifampicin</a>, or <a href="Phenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenytoin" title="Phenytoin">phenytoin</a>) may result in accelerated metabolism of cyclophosphamide into its active metabolites, increasing both pharmacologic and toxic effects of the drug; alternatively, drugs that inhibit hepatic microsomal enzymes (e.g. corticosteroids, tricyclic antidepressants, or <a href="Allopurinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Allopurinol" title="Allopurinol">allopurinol</a>) result in slower conversion of cyclophosphamide into its metabolites and consequently reduced therapeutic and toxic effects.<span class="mw-ref" id="cite_ref-42"><a href="#cite_note-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span></p>

<p>Cyclophosphamide reduces plasma pseudocholinesterase activity and may result in prolonged neuromuscular blockade when administered concurrently with <a href="Suxamethonium_chloride.htm" tppabs="https://ptable.com/wiki/compounds/A/Succinylcholine" title="Succinylcholine" class="mw-redirect">succinylcholine</a>.<span class="mw-ref" id="cite_ref-43"><a href="#cite_note-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span><span class="mw-ref" id="cite_ref-44"><a href="#cite_note-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> Tricyclic antidepressants and other anticholinergic agents can result in delayed bladder emptying and prolonged bladder exposure to acrolein.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mechanism_of_action">Mechanism of action</h2></summary>
    
<p>The main effect of cyclophosphamide is due to its metabolite phosphoramide mustard. This metabolite is only formed in cells that have low levels of ALDH. Phosphoramide mustard forms DNA crosslinks both between and within DNA strands at <a href="Guanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Guanine" title="Guanine">guanine</a> N-7 positions (known as interstrand and intrastrand crosslinkages, respectively). This is irreversible and leads to cell apoptosis.<span class="mw-ref" id="cite_ref-45"><a href="#cite_note-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span></p>

<p>Cyclophosphamide has relatively little typical chemotherapy toxicity as ALDHs are present in relatively large concentrations in bone marrow stem cells, liver and intestinal epithelium. ALDHs protect these actively proliferating tissues against toxic effects of phosphoramide mustard and acrolein by converting <a href="Cyclophosphamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Aldophosphamide" title="Aldophosphamide" class="mw-redirect">aldophosphamide</a> to carboxycyclophosphamide that does not give rise to the toxic metabolites phosphoramide mustard and acrolein. This is because carboxycyclophosphamide cannot undergo β-elimination (the carboxylate acts as an electron-donating group, nullifying the potential for transformation), preventing nitrogen mustard activation and subsequent alkylation.<span class="mw-ref" id="cite_ref-pmid19786984_25-1"><a href="#cite_note-pmid19786984-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span><span class="mw-ref" id="cite_ref-pmid2996550_46-0"><a href="#cite_note-pmid2996550-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span><span class="mw-ref" id="cite_ref-pmid1277209_47-0"><a href="#cite_note-pmid1277209-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span></p>

<p>Cyclophosphamide induces beneficial immunomodulatory effects in adaptive immunotherapy. Suggested mechanisms include:<span class="mw-ref" id="cite_ref-48"><a href="#cite_note-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span></p>

<ol><li>Elimination of T regulatory cells (CD4<sup>+</sup>CD25<sup>+</sup> T cells) in naive and tumor-bearing hosts</li>
<li>Induction of T cell growth factors, such as type I IFNs, and/or</li>
<li>Enhanced grafting of adoptively transferred, tumor-reactive effector T cells by the creation of an immunologic space niche.</li></ol>

<p>Thus, cyclophosphamide preconditioning of recipient hosts (for donor T cells) has been used to enhance immunity in naïve hosts, and to enhance adoptive T cell immunotherapy regimens, as well as active vaccination strategies, inducing objective antitumor immunity.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>As reported by O. M. Colvin in his study of the development of cyclophosphamide and its clinical applications,</p>

<blockquote><p>Phosphoramide mustard, one of the principal toxic metabolites of cyclophosphamide, was synthesized and reported by Friedman and Seligman in 1954<span class="mw-ref" id="cite_ref-49"><a href="#cite_note-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span> …It was postulated that the presence of the phosphate bond to the nitrogen atom could inactivate the nitrogen mustard moiety, but the phosphate bond would be cleaved in gastric cancers and other tumors which had a high phosphamidase content. However, in studies carried out after the clinical efficacy of cyclophosphamide was demonstrated, phosphoramide mustard proved to be cytotoxic <i>in vitro</i> (footnote omitted), but to have a low therapeutic index <i>in vivo</i>.<span class="mw-ref" id="cite_ref-50"><a href="#cite_note-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span></p></blockquote>

<p>Cyclophosphamide and the related nitrogen mustard–derived alkylating agent <a href="Ifosfamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Ifosfamide" title="Ifosfamide">ifosfamide</a> were developed by Norbert Brock and ASTA (now Baxter Oncology).<span class="mw-ref" id="cite_ref-51"><a href="#cite_note-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span>  Brock and his team synthesised and screened more than 1,000 candidate oxazaphosphorine compounds.<span class="mw-ref" id="cite_ref-52"><a href="#cite_note-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span> They converted the base nitrogen mustard into a nontoxic "transport form". This transport form was a prodrug, subsequently actively transported into cancer cells. Once in the cells, the prodrug was enzymatically converted into the active, toxic form. The first clinical trials were published at the end of the 1950s.<span class="mw-ref" id="cite_ref-53"><a href="#cite_note-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span><span class="mw-ref" id="cite_ref-54"><a href="#cite_note-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span><span class="mw-ref" id="cite_ref-55"><a href="#cite_note-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> In 1959 it became the eighth cytotoxic anticancer agent to be approved by the FDA.<span class="mw-ref" id="cite_ref-pmid19786984_25-2"><a href="#cite_note-pmid19786984-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    
<p>The abbreviation CP is common, although abbreviating drug names is not best practice in medicine.<span class="mw-ref" id="cite_ref-ISMP_list_do_not_abbreviate_56-0"><a href="#cite_note-ISMP_list_do_not_abbreviate-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Research">Research</h2></summary>
    
<p>Because of its impact on the immune system, it is used in animal studies. Rodents are injected intraperitoneally with either a single dose of 150<span>&nbsp;</span>mg/kg or two doses (150 and 100<span>&nbsp;</span>mg/kg) spread over two days.<span class="mw-ref" id="cite_ref-57"><a href="#cite_note-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span> This can be used for applications such as:</p>
<ul><li>The EPA may be concerned about potential human pathogenicity of an engineered microbe when conducting an MCAN review. Particularly for bacteria with potential consumer exposure they require testing of the microbe on immuno-compromised rats.<span class="mw-ref" id="cite_ref-58"><a href="#cite_note-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span></li>
<li>Cyclophosphamide provides a positive control when studying immune-response of a new drug.<span class="mw-ref" id="cite_ref-59"><a href="#cite_note-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span></li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist columns references-column-width" style="-moz-column-width: 32em; -webkit-column-width: 32em; column-width: 32em; list-style-type: decimal;">
<ol class="mw-references references"><li id="cite_note-1"> <span id="mw-reference-text-cite_note-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.oxforddictionaries.com/definition/english/cyclophosphamide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.oxforddictionaries.com/definition/english/cyclophosphamide'" tppabs="https://www.oxforddictionaries.com/definition/english/cyclophosphamide" class="external text external">"cyclophosphamide – definition of cyclophosphamide in English from the Oxford dictionary"</a>. OxfordDictionaries.com<span class="reference-accessdate">. Retrieved <span class="nowrap">2016-01-20</span></span>.</cite></span></li><li id="cite_note-2"> <span id="mw-reference-text-cite_note-2" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.merriam-webster.com/dictionary/cyclophosphamide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.merriam-webster.com/dictionary/cyclophosphamide'" tppabs="https://www.merriam-webster.com/dictionary/cyclophosphamide" class="external text external">"cyclophosphamide"</a>. <i>Merriam-Webster Dictionary</i>.</cite></span></li><li id="cite_note-3"> <span id="mw-reference-text-cite_note-3" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.cancer.gov/drugdictionary/?CdrID=39748  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cancer.gov/drugdictionary/?CdrID=39748'" tppabs="http://www.cancer.gov/drugdictionary/?CdrID=39748" class="external text external">"NCI Drug Dictionary"</a>. <i>National Cancer Institute</i>. 2 February 2011. <a href="javascript:if(confirm('https://web.archive.org/web/20150425042348/http://www.cancer.gov/drugdictionary?CdrID=39748  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150425042348/http://www.cancer.gov/drugdictionary?CdrID=39748'" tppabs="https://web.archive.org/web/20150425042348/http://www.cancer.gov/drugdictionary?CdrID=39748" class="external text external">Archived</a> from the original on 25 April 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">20 December</span> 2016</span>.</cite></span></li><li id="cite_note-AHFS2016-4"> <span id="mw-reference-text-cite_note-AHFS2016-4" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/cyclophosphamide.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/cyclophosphamide.html'" tppabs="https://www.drugs.com/monograph/cyclophosphamide.html" class="external text external">"Cyclophosphamide"</a>. The American Society of Health-System Pharmacists. <a href="javascript:if(confirm('https://web.archive.org/web/20170102075231/https://www.drugs.com/monograph/cyclophosphamide.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170102075231/https://www.drugs.com/monograph/cyclophosphamide.html'" tppabs="https://web.archive.org/web/20170102075231/https://www.drugs.com/monograph/cyclophosphamide.html" class="external text external">Archived</a> from the original on 2 January 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">8 December</span> 2016</span>.</cite></span></li><li id="cite_note-Pagnoux-5"> <span id="mw-reference-text-cite_note-Pagnoux-5" class="mw-reference-text"><cite id="CITEREFPagnoux2016" class="citation journal cs1">Pagnoux C (September 2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058451  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058451'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058451" class="external text external">"Updates in ANCA-associated vasculitis"</a>. <i>European Journal of Rheumatology</i>. <b>3</b> (3): 122–133. doi:<a href="javascript:if(confirm('https://doi.org/10.5152%2Feurjrheum.2015.0043  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.5152%2Feurjrheum.2015.0043'" tppabs="https://doi.org/10.5152%2Feurjrheum.2015.0043" class="external text external">10.5152/eurjrheum.2015.0043</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058451  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058451'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058451" class="external text external">5058451</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27733943  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27733943'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27733943" class="external text external">27733943</a>.</cite></span></li><li id="cite_note-WHO21st-6"> <span id="mw-reference-text-cite_note-WHO21st-6" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2019" class="citation book cs1">World Health Organization (2019). <i>World Health Organization model list of essential medicines: 21st list 2019</i>. Geneva: World Health Organization. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/10665%2F325771  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F325771'" tppabs="https://hdl.handle.net/10665%2F325771" class="external text external">10665/325771</a></span>. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.</cite></span></li><li id="cite_note-MD-7"> <span id="mw-reference-text-cite_note-MD-7" class="mw-reference-text"><cite id="CITEREFBrayfield,_A2017" class="citation web cs1">Brayfield, A, ed. (9 January 2017). <a href="javascript:if(confirm('https://www.medicinescomplete.com/mc/martindale/current/1825-k.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.medicinescomplete.com/mc/martindale/current/1825-k.htm'" tppabs="https://www.medicinescomplete.com/mc/martindale/current/1825-k.htm" class="external text external">"Cyclophosphamide: Martindale: The Complete Drug Reference"</a>. <i>MedicinesComplete</i>. London, UK: Pharmaceutical Press<span class="reference-accessdate">. Retrieved <span class="nowrap">12 August</span> 2017</span>.</cite></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite class="citation book cs1"><i>Brenner &amp; Rector's The Kidney</i> (11th ed.). Philadelphia: Elsevier. 2020. pp.<span>&nbsp;</span>1007–1091. ISBN<span>&nbsp;</span><bdi>978-0-323-53265-5</bdi>.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><cite id="CITEREFDeVriezeHurley2019" class="citation book cs1">DeVrieze BW, Hurley JA (2019). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/books/NBK459291/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/books/NBK459291/'" tppabs="https://www.ncbi.nlm.nih.gov/books/NBK459291/" class="external text external">"Goodpasture Syndrome (Anti-glomerular Basement Membrane Antibody Disease)"</a>. <i>StatPearls</i>. Treasure Island, USA: StatPearls Publishing. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29083697  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29083697'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29083697" class="external text external">29083697</a>.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite id="CITEREFLa_MantiaMilaneseMascoliD'Amico2007" class="citation journal cs1">La Mantia, L.; Milanese, C.; Mascoli, N.; D'Amico, R.; Weinstock-Guttman, B. (2007-01-24). "Cyclophosphamide for multiple sclerosis". <i>Cochrane Database of Systematic Reviews</i> (1): CD002819. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD002819.pub2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD002819.pub2'" tppabs="https://doi.org/10.1002%2F14651858.CD002819.pub2" class="external text external">10.1002/14651858.CD002819.pub2</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1469-493X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1469-493X'" tppabs="https://www.worldcat.org/issn/1469-493X" class="external text external">1469-493X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17253481  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17253481'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17253481" class="external text external">17253481</a>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite id="CITEREFDavisReimold2017" class="citation journal cs1">Davis LS, Reimold AM (April 2017). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850311  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850311'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850311" class="external text external">"Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus"</a>. <i>Rheumatology</i>. <b>56</b> (suppl_1): i100–i113. doi:<a href="javascript:if(confirm('https://doi.org/10.1093%2Frheumatology%2Fkew417  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Frheumatology%2Fkew417'" tppabs="https://doi.org/10.1093%2Frheumatology%2Fkew417" class="external text external">10.1093/rheumatology/kew417</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850311  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850311'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850311" class="external text external">5850311</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28375452  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28375452'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28375452" class="external text external">28375452</a>.</cite></span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text"><cite id="CITEREFGertz2014" class="citation journal cs1">Gertz MA (December 2014). "Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment". <i>American Journal of Hematology</i>. <b>89</b> (12): 1132–40. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fajh.23828  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fajh.23828'" tppabs="https://doi.org/10.1002%2Fajh.23828" class="external text external">10.1002/ajh.23828</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25407896  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25407896'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25407896" class="external text external">25407896</a>.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite id="CITEREFOr-GevaReisner2016" class="citation journal cs1">Or-Geva N, Reisner Y (March 2016). "The evolution of T-cell depletion in haploidentical stem-cell transplantation". <i>British Journal of Haematology</i>. <b>172</b> (5): 667–84. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fbjh.13868  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fbjh.13868'" tppabs="https://doi.org/10.1111%2Fbjh.13868" class="external text external">10.1111/bjh.13868</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26684279  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26684279'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26684279" class="external text external">26684279</a>.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite id="CITEREFFuchs2015" class="citation journal cs1">Fuchs EJ (June 2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634886  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634886'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634886" class="external text external">"HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide"</a>. <i>Bone Marrow Transplantation</i>. 50 Suppl 2: S31–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fbmt.2015.92  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fbmt.2015.92'" tppabs="https://doi.org/10.1038%2Fbmt.2015.92" class="external text external">10.1038/bmt.2015.92</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634886  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634886'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634886" class="external text external">4634886</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26039204  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26039204'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26039204" class="external text external">26039204</a>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite id="CITEREFRobinsonO'DonnellFuchsLuznik2016" class="citation journal cs1">Robinson TM, O'Donnell PV, Fuchs EJ, Luznik L (April 2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806368  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806368'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806368" class="external text external">"Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide"</a>. <i>Seminars in Hematology</i>. <b>53</b> (2): 90–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1053%2Fj.seminhematol.2016.01.005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1053%2Fj.seminhematol.2016.01.005'" tppabs="https://doi.org/10.1053%2Fj.seminhematol.2016.01.005" class="external text external">10.1053/j.seminhematol.2016.01.005</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806368  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806368'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806368" class="external text external">4806368</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27000732  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27000732'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27000732" class="external text external">27000732</a>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite id="CITEREFEnnsRoederChanAli-Khan_Catts1999" class="citation journal cs1">Enns GM, Roeder E, Chan RT, Ali-Khan Catts Z, Cox VA, Golabi M (September 1999). "Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype?". <i>American Journal of Medical Genetics</i>. <b>86</b> (3): 237–41. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F%28SICI%291096-8628%2819990917%2986%3A3%3C237%3A%3AAID-AJMG8%3E3.0.CO%3B2-V  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F%28SICI%291096-8628%2819990917%2986%3A3%3C237%3A%3AAID-AJMG8%3E3.0.CO%3B2-V'" tppabs="https://doi.org/10.1002%2F%28SICI%291096-8628%2819990917%2986%3A3%3C237%3A%3AAID-AJMG8%3E3.0.CO%3B2-V" class="external text external">10.1002/(SICI)1096-8628(19990917)86:3<span>&lt;</span>237::AID-AJMG8<span>&gt;</span>3.0.CO;2-V</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10482872  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10482872'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10482872" class="external text external">10482872</a>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite id="CITEREFSinghFriesWilliamsZatarain1991" class="citation journal cs1">Singh G, Fries JF, Williams CA, Zatarain E, Spitz P, Bloch DA (February 1991). "Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis". <i>The Journal of Rheumatology</i>. <b>18</b> (2): 188–94. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1673721  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1673721'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1673721" class="external text external">1673721</a>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite id="CITEREFLohrmann1984" class="citation journal cs1">Lohrmann HP (1984). "The problem of permanent bone marrow damage after cytotoxic drug treatment". <i>Oncology</i>. <b>41</b> (3): 180–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1159%2F000225819  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1159%2F000225819'" tppabs="https://doi.org/10.1159%2F000225819" class="external text external">10.1159/000225819</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6374556  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6374556'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6374556" class="external text external">6374556</a>.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite id="CITEREFSinghHossainKotbWells2016" class="citation journal cs1">Singh JA, Hossain A, Kotb A, Wells G (September 2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022202  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022202'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022202" class="external text external">"Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis"</a>. <i>BMC Medicine</i>. <b>14</b> (1): 137. doi:<a href="javascript:if(confirm('https://doi.org/10.1186%2Fs12916-016-0673-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1186%2Fs12916-016-0673-8'" tppabs="https://doi.org/10.1186%2Fs12916-016-0673-8" class="external text external">10.1186/s12916-016-0673-8</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022202  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022202'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022202" class="external text external">5022202</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27623861  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27623861'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27623861" class="external text external">27623861</a>.</cite></span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text"><cite id="CITEREFTwohigMatthay1990" class="citation journal cs1">Twohig KJ, Matthay RA (March 1990). "Pulmonary effects of cytotoxic agents other than bleomycin". <i>Clinics in Chest Medicine</i>. <b>11</b> (1): 31–54. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1691069  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1691069'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1691069" class="external text external">1691069</a>.</cite></span></li><li id="cite_note-21"> <span id="mw-reference-text-cite_note-21" class="mw-reference-text"><cite id="CITEREFMalikMyersDeRemeeSpecks1996" class="citation journal cs1">Malik SW, Myers JL, DeRemee RA, Specks U (December 1996). "Lung toxicity associated with cyclophosphamide use. Two distinct patterns". <i>American Journal of Respiratory and Critical Care Medicine</i>. <b>154</b> (6 Pt 1): 1851–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1164%2Fajrccm.154.6.8970380  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1164%2Fajrccm.154.6.8970380'" tppabs="https://doi.org/10.1164%2Fajrccm.154.6.8970380" class="external text external">10.1164/ajrccm.154.6.8970380</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8970380  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8970380'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8970380" class="external text external">8970380</a>.</cite></span></li><li id="cite_note-22"> <span id="mw-reference-text-cite_note-22" class="mw-reference-text"><cite id="CITEREFFloydNguyenLobinsBashir2005" class="citation journal cs1">Floyd JD, Nguyen DT, Lobins RL, Bashir Q, Doll DC, Perry MC (October 2005). "Cardiotoxicity of cancer therapy". <i>Journal of Clinical Oncology</i>. <b>23</b> (30): 7685–96. doi:<a href="javascript:if(confirm('https://doi.org/10.1200%2FJCO.2005.08.789  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1200%2FJCO.2005.08.789'" tppabs="https://doi.org/10.1200%2FJCO.2005.08.789" class="external text external">10.1200/JCO.2005.08.789</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16234530  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16234530'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16234530" class="external text external">16234530</a>.</cite></span></li><li id="cite_note-23"> <span id="mw-reference-text-cite_note-23" class="mw-reference-text"><cite id="CITEREFBresslerHuston1985" class="citation journal cs1">Bressler RB, Huston DP (March 1985). "Water intoxication following moderate-dose intravenous cyclophosphamide". <i>Archives of Internal Medicine</i>. <b>145</b> (3): 548–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Farchinte.145.3.548  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Farchinte.145.3.548'" tppabs="https://doi.org/10.1001%2Farchinte.145.3.548" class="external text external">10.1001/archinte.145.3.548</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3977522  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3977522'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3977522" class="external text external">3977522</a>.</cite></span></li><li id="cite_note-24"> <span id="mw-reference-text-cite_note-24" class="mw-reference-text"><cite id="CITEREFSalidoMacarronHernández-GarcíaD'Cruz2003" class="citation journal cs1">Salido M, Macarron P, Hernández-García C, D'Cruz DP, Khamashta MA, Hughes GR (2003). "Water intoxication induced by low-dose cyclophosphamide in two patients with systemic lupus erythematosus". <i>Lupus</i>. <b>12</b> (8): 636–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1191%2F0961203303lu421cr  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1191%2F0961203303lu421cr'" tppabs="https://doi.org/10.1191%2F0961203303lu421cr" class="external text external">10.1191/0961203303lu421cr</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12945725  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12945725'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12945725" class="external text external">12945725</a>.</cite></span></li><li id="cite_note-pmid19786984-25"> <span id="mw-reference-text-cite_note-pmid19786984-25" class="mw-reference-text"><cite id="CITEREFEmadiJonesBrodsky2009" class="citation journal cs1">Emadi A, Jones RJ, Brodsky RA (November 2009). "Cyclophosphamide and cancer: golden anniversary". <i>Nature Reviews. Clinical Oncology</i>. <b>6</b> (11): 638–47. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fnrclinonc.2009.146  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fnrclinonc.2009.146'" tppabs="https://doi.org/10.1038%2Fnrclinonc.2009.146" class="external text external">10.1038/nrclinonc.2009.146</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19786984  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19786984'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19786984" class="external text external">19786984</a>.</cite></span></li><li id="cite_note-26"> <span id="mw-reference-text-cite_note-26" class="mw-reference-text"><cite id="CITEREFMonachArnoldMerkel2010" class="citation journal cs1">Monach PA, Arnold LM, Merkel PA (January 2010). "Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review". <i>Arthritis and Rheumatism</i>. <b>62</b> (1): 9–21. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fart.25061  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fart.25061'" tppabs="https://doi.org/10.1002%2Fart.25061" class="external text external">10.1002/art.25061</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20039416  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20039416'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20039416" class="external text external">20039416</a>.</cite></span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite id="CITEREFBoumpasAustinVaughnKlippel1992" class="citation journal cs1">Boumpas DT, Austin HA, Vaughn EM, Klippel JH, Steinberg AD, Yarboro CH, Balow JE (September 1992). <a href="javascript:if(confirm('https://zenodo.org/record/1258313  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://zenodo.org/record/1258313'" tppabs="https://zenodo.org/record/1258313" class="external text external">"Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis"</a>. <i>Lancet</i>. <b>340</b> (8822): 741–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0140-6736%2892%2992292-n  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0140-6736%2892%2992292-n'" tppabs="https://doi.org/10.1016%2F0140-6736%2892%2992292-n" class="external text external">10.1016/0140-6736(92)92292-n</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1356175  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1356175'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1356175" class="external text external">1356175</a>.</cite></span></li><li id="cite_note-28"> <span id="mw-reference-text-cite_note-28" class="mw-reference-text"><cite id="CITEREFPryorBolognaKahl1996" class="citation journal cs1">Pryor BD, Bologna SG, Kahl LE (September 1996). "Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus". <i>Arthritis and Rheumatism</i>. <b>39</b> (9): 1475–82. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fart.1780390906  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fart.1780390906'" tppabs="https://doi.org/10.1002%2Fart.1780390906" class="external text external">10.1002/art.1780390906</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8814058  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8814058'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8814058" class="external text external">8814058</a>.</cite></span></li><li id="cite_note-29"> <span id="mw-reference-text-cite_note-29" class="mw-reference-text"><cite id="CITEREFSuryaprasadStone2008" class="citation journal cs1">Suryaprasad A, Stone JH (July 2008). "When is it safe to stop Pneumocystis jiroveci pneumonia prophylaxis? Insights from three cases complicating autoimmune diseases". <i>Arthritis and Rheumatism</i>. <b>59</b> (7): 1034–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fart.23822  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fart.23822'" tppabs="https://doi.org/10.1002%2Fart.23822" class="external text external">10.1002/art.23822</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18576286  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18576286'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18576286" class="external text external">18576286</a>.</cite></span></li><li id="cite_note-Kronbichler2015-30"> <span id="mw-reference-text-cite_note-Kronbichler2015-30" class="mw-reference-text"><cite id="CITEREFKronbichlerJayneMayer2015" class="citation journal cs1">Kronbichler A, Jayne DR, Mayer G (March 2015). "Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis". <i>European Journal of Clinical Investigation</i> (Review). <b>45</b> (3): 346–68. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Feci.12410  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Feci.12410'" tppabs="https://doi.org/10.1111%2Feci.12410" class="external text external">10.1111/eci.12410</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25627555  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25627555'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25627555" class="external text external">25627555</a>.</cite></span></li><li id="cite_note-31"> <span id="mw-reference-text-cite_note-31" class="mw-reference-text"><cite id="CITEREFBalowAustinTsokosAntonovych1987" class="citation journal cs1">Balow JE, Austin HA, Tsokos GC, Antonovych TT, Steinberg AD, Klippel JH (January 1987). "NIH conference. Lupus nephritis". <i>Annals of Internal Medicine</i>. <b>106</b> (1): 79–94. doi:<a href="javascript:if(confirm('https://doi.org/10.7326%2F0003-4819-106-1-79  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.7326%2F0003-4819-106-1-79'" tppabs="https://doi.org/10.7326%2F0003-4819-106-1-79" class="external text external">10.7326/0003-4819-106-1-79</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3789582  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3789582'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3789582" class="external text external">3789582</a>.</cite></span></li><li id="cite_note-32"> <span id="mw-reference-text-cite_note-32" class="mw-reference-text"><cite id="CITEREFPeritiMazzeiMini2002" class="citation journal cs1">Periti P, Mazzei T, Mini E (2002). "Clinical pharmacokinetics of depot leuprorelin". <i>Clinical Pharmacokinetics</i>. <b>41</b> (7): 485–504. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003088-200241070-00003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003088-200241070-00003'" tppabs="https://doi.org/10.2165%2F00003088-200241070-00003" class="external text external">10.2165/00003088-200241070-00003</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12083977  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12083977'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12083977" class="external text external">12083977</a>.</cite></span></li><li id="cite_note-33"> <span id="mw-reference-text-cite_note-33" class="mw-reference-text"><cite id="CITEREFBernatskyClarkeSuissa2008" class="citation journal cs1">Bernatsky S, Clarke AE, Suissa S (February 2008). <a href="javascript:if(confirm('https://doi.org/10.1001/archinternmed.2007.107  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001/archinternmed.2007.107'" tppabs="https://doi.org/10.1001/archinternmed.2007.107" class="external text external">"Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis"</a>. <i>Archives of Internal Medicine</i>. <b>168</b> (4): 378–81. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1001%2Farchinternmed.2007.107  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Farchinternmed.2007.107'" tppabs="https://doi.org/10.1001%2Farchinternmed.2007.107" class="external text external">10.1001/archinternmed.2007.107</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18299492  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18299492'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18299492" class="external text external">18299492</a>.</cite></span></li><li id="cite_note-34"> <span id="mw-reference-text-cite_note-34" class="mw-reference-text"><cite id="CITEREFRadisKahlBakerWasko1995" class="citation journal cs1">Radis CD, Kahl LE, Baker GL, Wasko MC, Cash JM, Gallatin A, Stolzer BL, Agarwal AK, Medsger TA, Kwoh CK (August 1995). "Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study". <i>Arthritis and Rheumatism</i>. <b>38</b> (8): 1120–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fart.1780380815  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fart.1780380815'" tppabs="https://doi.org/10.1002%2Fart.1780380815" class="external text external">10.1002/art.1780380815</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7639809  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7639809'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7639809" class="external text external">7639809</a>.</cite></span></li><li id="cite_note-35"> <span id="mw-reference-text-cite_note-35" class="mw-reference-text"><cite id="CITEREFLarson2007" class="citation journal cs1">Larson RA (2007). <a href="javascript:if(confirm('https://doi.org/10.1182/asheducation-2007.1.453  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1182/asheducation-2007.1.453'" tppabs="https://doi.org/10.1182/asheducation-2007.1.453" class="external text external">"Etiology and management of therapy-related myeloid leukemia"</a>. <i>Hematology. American Society of Hematology. Education Program</i>. <b>2007</b>: 453–9. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1182%2Fasheducation-2007.1.453  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1182%2Fasheducation-2007.1.453'" tppabs="https://doi.org/10.1182%2Fasheducation-2007.1.453" class="external text external">10.1182/asheducation-2007.1.453</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18024664  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18024664'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18024664" class="external text external">18024664</a>.</cite></span></li><li id="cite_note-pmid4393764-36"> <span id="mw-reference-text-cite_note-pmid4393764-36" class="mw-reference-text"><cite id="CITEREFCohenJao1970" class="citation journal cs1">Cohen JL, Jao JY (August 1970). <a href="javascript:if(confirm('http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=4393764  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=4393764'" tppabs="http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=4393764" class="external text external">"Enzymatic basis of cyclophosphamide activation by hepatic microsomes of the rat"</a>. <i>The Journal of Pharmacology and Experimental Therapeutics</i>. <b>174</b> (2): 206–10. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/4393764  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/4393764'" tppabs="https://pubmed.ncbi.nlm.nih.gov/4393764" class="external text external">4393764</a>.</cite></span></li><li id="cite_note-37"> <span id="mw-reference-text-cite_note-37" class="mw-reference-text"><cite id="CITEREFHuttunenRaunioRautio2011" class="citation journal cs1">Huttunen KM, Raunio H, Rautio J (September 2011). "Prodrugs--from serendipity to rational design". <i>Pharmacological Reviews</i>. <b>63</b> (3): 750–71. doi:<a href="javascript:if(confirm('https://doi.org/10.1124%2Fpr.110.003459  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1124%2Fpr.110.003459'" tppabs="https://doi.org/10.1124%2Fpr.110.003459" class="external text external">10.1124/pr.110.003459</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21737530  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21737530'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21737530" class="external text external">21737530</a>.</cite></span></li><li id="cite_note-pmid10803453-38"> <span id="mw-reference-text-cite_note-pmid10803453-38" class="mw-reference-text"><cite id="CITEREFBoddyYule2000" class="citation journal cs1">Boddy AV, Yule SM (April 2000). "Metabolism and pharmacokinetics of oxazaphosphorines". <i>Clinical Pharmacokinetics</i>. <b>38</b> (4): 291–304. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003088-200038040-00001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003088-200038040-00001'" tppabs="https://doi.org/10.2165%2F00003088-200038040-00001" class="external text external">10.2165/00003088-200038040-00001</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10803453  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10803453'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10803453" class="external text external">10803453</a>.</cite></span></li><li id="cite_note-39"> <span id="mw-reference-text-cite_note-39" class="mw-reference-text"><cite id="CITEREFWiernikDuncan1971" class="citation journal cs1">Wiernik PH, Duncan JH (May 1971). "Cyclophosphamide in human milk". <i>Lancet</i>. <b>1</b> (7705): 912. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0140-6736%2871%2992474-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0140-6736%2871%2992474-3'" tppabs="https://doi.org/10.1016%2Fs0140-6736%2871%2992474-3" class="external text external">10.1016/s0140-6736(71)92474-3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/4102054  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/4102054'" tppabs="https://pubmed.ncbi.nlm.nih.gov/4102054" class="external text external">4102054</a>.</cite></span></li><li id="cite_note-pmid_20446865-40"> <span id="mw-reference-text-cite_note-pmid_20446865-40" class="mw-reference-text"><cite id="CITEREFGiraud2010" class="citation cs2">Giraud, B;  et al. (2010), "Oxazaphosphorines: new therapeutic strategies for an old class of drugs", <i>Expert Opin Drug Metab Toxicol</i>, <b>6</b> (8): 919–938, doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F17425255.2010.487861  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F17425255.2010.487861'" tppabs="https://doi.org/10.1517%2F17425255.2010.487861" class="external text external">10.1517/17425255.2010.487861</a>, PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20446865  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20446865'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20446865" class="external text external">20446865</a>.</cite></span></li><li id="cite_note-41"> <span id="mw-reference-text-cite_note-41" class="mw-reference-text"><cite id="CITEREFHaubitzBohnenstengelBrunkhorstSchwab2002" class="citation journal cs1">Haubitz M, Bohnenstengel F, Brunkhorst R, Schwab M, Hofmann U, Busse D (April 2002). "Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency". <i>Kidney International</i>. <b>61</b> (4): 1495–501. doi:<a href="javascript:if(confirm('https://doi.org/10.1046%2Fj.1523-1755.2002.00279.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1046%2Fj.1523-1755.2002.00279.x'" tppabs="https://doi.org/10.1046%2Fj.1523-1755.2002.00279.x" class="external text external">10.1046/j.1523-1755.2002.00279.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11918757  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11918757'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11918757" class="external text external">11918757</a>.</cite></span></li><li id="cite_note-42"> <span id="mw-reference-text-cite_note-42" class="mw-reference-text"><cite id="CITEREFDonelliBartosekGuaitaniMartini1976" class="citation journal cs1">Donelli MG, Bartosek I, Guaitani A, Martini A, Colombo T, Pacciarini MA, Modica R (April 1976). "Importance of pharmacokinetic studies on cyclophosphamide (NSC-26271) in understanding its cytotoxic effect". <i>Cancer Treatment Reports</i>. <b>60</b> (4): 395–401. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1277213  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1277213'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1277213" class="external text external">1277213</a>.</cite></span></li><li id="cite_note-43"> <span id="mw-reference-text-cite_note-43" class="mw-reference-text"><cite id="CITEREFKoseogluChiangChan1999" class="citation journal cs1">Koseoglu V, Chiang J, Chan KW (December 1999). <a href="javascript:if(confirm('https://doi.org/10.1038/sj.bmt.1702097  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038/sj.bmt.1702097'" tppabs="https://doi.org/10.1038/sj.bmt.1702097" class="external text external">"Acquired pseudocholinesterase deficiency after high-dose cyclophosphamide"</a>. <i>Bone Marrow Transplantation</i>. <b>24</b> (12): 1367–8. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1038%2Fsj.bmt.1702097  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fsj.bmt.1702097'" tppabs="https://doi.org/10.1038%2Fsj.bmt.1702097" class="external text external">10.1038/sj.bmt.1702097</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10627651  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10627651'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10627651" class="external text external">10627651</a>.</cite></span></li><li id="cite_note-44"> <span id="mw-reference-text-cite_note-44" class="mw-reference-text"><cite id="CITEREFVigourouxVoltaire1995" class="citation journal cs1">Vigouroux D, Voltaire L (1995). "[Prolonged neuromuscular block induced by mivacurium in a patient treated with cyclophosphamide]" <span>[</span>Prolonged neuromuscular block induced by mivacurium in a patient treated with cyclophosphamide<span>]</span>. <i>Annales Francaises d'Anesthesie et de Reanimation</i> (in French). <b>14</b> (6): 508–10. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0750-7658%2805%2980493-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0750-7658%2805%2980493-9'" tppabs="https://doi.org/10.1016%2FS0750-7658%2805%2980493-9" class="external text external">10.1016/S0750-7658(05)80493-9</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8745976  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8745976'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8745976" class="external text external">8745976</a>. INIST:<a href="javascript:if(confirm('https://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2947795  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2947795'" tppabs="https://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2947795" class="external text external">2947795</a>.</cite></span></li><li id="cite_note-45"> <span id="mw-reference-text-cite_note-45" class="mw-reference-text"><cite id="CITEREFHallTilby1992" class="citation journal cs1">Hall AG, Tilby MJ (September 1992). "Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies". <i>Blood Reviews</i>. <b>6</b> (3): 163–73. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0268-960X%2892%2990028-O  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0268-960X%2892%2990028-O'" tppabs="https://doi.org/10.1016%2F0268-960X%2892%2990028-O" class="external text external">10.1016/0268-960X(92)90028-O</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1422285  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1422285'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1422285" class="external text external">1422285</a>.</cite></span></li><li id="cite_note-pmid2996550-46"> <span id="mw-reference-text-cite_note-pmid2996550-46" class="mw-reference-text"><cite id="CITEREFKohnSladek1985" class="citation journal cs1">Kohn FR, Sladek NE (October 1985). "Aldehyde dehydrogenase activity as the basis for the relative insensitivity of murine pluripotent hematopoietic stem cells to oxazaphosphorines". <i>Biochemical Pharmacology</i>. <b>34</b> (19): 3465–71. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0006-2952%2885%2990719-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0006-2952%2885%2990719-1'" tppabs="https://doi.org/10.1016%2F0006-2952%2885%2990719-1" class="external text external">10.1016/0006-2952(85)90719-1</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2996550  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2996550'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2996550" class="external text external">2996550</a>.</cite></span></li><li id="cite_note-pmid1277209-47"> <span id="mw-reference-text-cite_note-pmid1277209-47" class="mw-reference-text"><cite id="CITEREFFriedmanWodinskyMyles1976" class="citation journal cs1">Friedman OM, Wodinsky I, Myles A (April 1976). "Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective". <i>Cancer Treatment Reports</i>. <b>60</b> (4): 337–46. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1277209  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1277209'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1277209" class="external text external">1277209</a>.</cite></span></li><li id="cite_note-48"> <span id="mw-reference-text-cite_note-48" class="mw-reference-text"><cite id="CITEREFSistiguViaudChaputBracci2011" class="citation journal cs1">Sistigu A, Viaud S, Chaput N, Bracci L, Proietti E, Zitvogel L (July 2011). "Immunomodulatory effects of cyclophosphamide and implementations for vaccine design". <i>Seminars in Immunopathology</i>. <b>33</b> (4): 369–83. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00281-011-0245-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00281-011-0245-0'" tppabs="https://doi.org/10.1007%2Fs00281-011-0245-0" class="external text external">10.1007/s00281-011-0245-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21611872  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21611872'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21611872" class="external text external">21611872</a>.</cite></span></li><li id="cite_note-49"> <span id="mw-reference-text-cite_note-49" class="mw-reference-text"><cite id="CITEREFFriedmanSeligman1954" class="citation journal cs1">Friedman OM, Seligman AM (1954). "Preparation of N-Phosphorylated Derivatives of Bis-β-chloroethylamine1a". <i>Journal of the American Chemical Society</i>. <b>76</b> (3): 655–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fja01632a006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fja01632a006'" tppabs="https://doi.org/10.1021%2Fja01632a006" class="external text external">10.1021/ja01632a006</a>.</cite></span></li><li id="cite_note-50"> <span id="mw-reference-text-cite_note-50" class="mw-reference-text"><cite id="CITEREFColvin1999" class="citation journal cs1">Colvin OM (August 1999). "An overview of cyclophosphamide development and clinical applications". <i>Current Pharmaceutical Design</i>. <b>5</b> (8): 555–60. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10469891  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10469891'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10469891" class="external text external">10469891</a>.</cite></span></li><li id="cite_note-51"> <span id="mw-reference-text-cite_note-51" class="mw-reference-text"><span><a href="javascript:if(confirm('https://www.google.com/patents/US3018302  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.google.com/patents/US3018302'" tppabs="https://www.google.com/patents/US3018302" class="external text external">U.S. Patent 3,018,302</a></span></span></li><li id="cite_note-52"> <span id="mw-reference-text-cite_note-52" class="mw-reference-text"><cite id="CITEREFBrock1996" class="citation journal cs1">Brock N (August 1996). "The history of the oxazaphosphorine cytostatics". <i>Cancer</i>. <b>78</b> (3): 542–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C542%3A%3AAID-CNCR23%3E3.0.CO%3B2-Y  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C542%3A%3AAID-CNCR23%3E3.0.CO%3B2-Y'" tppabs="https://doi.org/10.1002%2F%28SICI%291097-0142%2819960801%2978%3A3%3C542%3A%3AAID-CNCR23%3E3.0.CO%3B2-Y" class="external text external">10.1002/(SICI)1097-0142(19960801)78:3<span>&lt;</span>542::AID-CNCR23<span>&gt;</span>3.0.CO;2-Y</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8697402  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8697402'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8697402" class="external text external">8697402</a>.</cite></span></li><li id="cite_note-53"> <span id="mw-reference-text-cite_note-53" class="mw-reference-text"><cite id="CITEREFWilmanns1958" class="citation book cs1">Wilmanns, Hilmar (1958). <i>Chemotherapie maligner Tumoren</i> <span>[</span><i>Chemotherapy of malignant tumors</i><span>]</span>. Asta-Forschung und Therapie (in German). OCLC<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/oclc/73296245  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/oclc/73296245'" tppabs="https://www.worldcat.org/oclc/73296245" class="external text external">73296245</a>.</cite></span></li><li id="cite_note-54"> <span id="mw-reference-text-cite_note-54" class="mw-reference-text"><cite id="CITEREFGrossWulf1959" class="citation journal cs1">Gross R, Wulf G (1959). "Klinische und experimentelle Erfahrungen mit zyk lischen und nichtzyklischen Phosphamidestern des N-Losl in der Chemotherapie von Tumoren" <span>[</span>Clinical and experimental experiences with metallic cyclical and non-cyclical Phosphamidestern the N-losl in the chemotherapy of tumors<span>]</span>. <i>Strahlentherapie</i> (in German). <b>41</b>: 361–7.</cite></span></li><li id="cite_note-55"> <span id="mw-reference-text-cite_note-55" class="mw-reference-text"><cite id="CITEREFBrock1989" class="citation journal cs1">Brock N (January 1989). <a href="javascript:if(confirm('http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=2491747  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=2491747'" tppabs="http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=2491747" class="external text external">"Oxazaphosphorine cytostatics: past-present-future. Seventh Cain Memorial Award lecture"</a>. <i>Cancer Research</i>. <b>49</b> (1): 1–7. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2491747  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2491747'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2491747" class="external text external">2491747</a>.</cite></span></li><li id="cite_note-ISMP_list_do_not_abbreviate-56"> <span id="mw-reference-text-cite_note-ISMP_list_do_not_abbreviate-56" class="mw-reference-text"><cite id="CITEREFInstitute_for_Safe_Medication_Practices" class="citation cs2">Institute for Safe Medication Practices, <a href="javascript:if(confirm('http://www.ismp.org/tools/errorproneabbreviations.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ismp.org/tools/errorproneabbreviations.pdf'" tppabs="http://www.ismp.org/tools/errorproneabbreviations.pdf" class="external text external"><i>ISMP's List of Error-Prone Abbreviations, Symbols, and Dose Designations</i></a> <span class="cs1-format">(PDF)</span>, <a href="javascript:if(confirm('https://web.archive.org/web/20111027133115/http://www.ismp.org/tools/errorproneabbreviations.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20111027133115/http://www.ismp.org/tools/errorproneabbreviations.pdf'" tppabs="https://web.archive.org/web/20111027133115/http://www.ismp.org/tools/errorproneabbreviations.pdf" class="external text external">archived</a> <span class="cs1-format">(PDF)</span> from the original on 2011-10-27.</cite></span></li><li id="cite_note-57"> <span id="mw-reference-text-cite_note-57" class="mw-reference-text"><cite id="CITEREFZuluagaSalazarRodriguezZapata2006" class="citation journal cs1">Zuluaga AF, Salazar BE, Rodriguez CA, Zapata AX, Agudelo M, Vesga O (March 2006). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1434751  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1434751'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1434751" class="external text external">"Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases"</a>. <i>BMC Infectious Diseases</i>. <b>6</b> (1): 55. doi:<a href="javascript:if(confirm('https://doi.org/10.1186%2F1471-2334-6-55  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1186%2F1471-2334-6-55'" tppabs="https://doi.org/10.1186%2F1471-2334-6-55" class="external text external">10.1186/1471-2334-6-55</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1434751  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1434751'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1434751" class="external text external">1434751</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16545113  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16545113'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16545113" class="external text external">16545113</a>.</cite></span></li><li id="cite_note-58"> <span id="mw-reference-text-cite_note-58" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.epa.gov/biotech_rule/pubs/submiss.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.epa.gov/biotech_rule/pubs/submiss.htm'" tppabs="http://www.epa.gov/biotech_rule/pubs/submiss.htm" class="external text external">"Archived copy"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20150621202223/http://www.epa.gov/biotech_rule/pubs/submiss.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150621202223/http://www.epa.gov/biotech_rule/pubs/submiss.htm'" tppabs="https://web.archive.org/web/20150621202223/http://www.epa.gov/biotech_rule/pubs/submiss.htm" class="external text external">Archived</a> from the original on 2015-06-21<span class="reference-accessdate">. Retrieved <span class="nowrap">2015-07-01</span></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (link)</span></span></li><li id="cite_note-59"> <span id="mw-reference-text-cite_note-59" class="mw-reference-text"><cite id="CITEREFHuyanLinGaoChen2011" class="citation journal cs1">Huyan XH, Lin YP, Gao T, Chen RY, Fan YM (September 2011). <a href="javascript:if(confirm('https://zenodo.org/record/895552  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://zenodo.org/record/895552'" tppabs="https://zenodo.org/record/895552" class="external text external">"Immunosuppressive effect of cyclophosphamide on white blood cells and lymphocyte subpopulations from peripheral blood of Balb/c mice"</a>. <i>International Immunopharmacology</i>. <b>11</b> (9): 1293–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.intimp.2011.04.011  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.intimp.2011.04.011'" tppabs="https://doi.org/10.1016%2Fj.intimp.2011.04.011" class="external text external">10.1016/j.intimp.2011.04.011</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21530682  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21530682'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21530682" class="external text external">21530682</a>.</cite></span></li></ol></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/Cyclophosphamide+(anhydrous)  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/Cyclophosphamide+(anhydrous)'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/Cyclophosphamide+(anhydrous)" class="external text external">"Cyclophosphamide"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li>
<li><span><a href="javascript:if(confirm('https://www.google.com/patents/US3018302  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.google.com/patents/US3018302'" tppabs="https://www.google.com/patents/US3018302" class="external text external">U.S. Patent 3,018,302</a></span> Novel cyclic phosphoric acid ester amides, and the production thereof. (patent for cyclophosphamide).</li></ul>
<div role="navigation" class="navbox" aria-labelledby="Intracellular_chemotherapeutic_agents_/_antineoplastic_agents_(L01)" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Intracellular_chemotherapeutic_agents_/_antineoplastic_agents_(L01)" style="font-size:114%;margin:0 4em">Intracellular chemotherapeutic agents<span>&nbsp;</span>/ antineoplastic agents (L01)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">SPs/MIs<br>(M phase)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Block microtubule assembly</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Vinca alkaloids</i> (<a href="Vinblastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vinblastine" title="Vinblastine">Vinblastine</a><sup>#</sup></li>
<li><a href="Vincristine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vincristine" title="Vincristine">Vincristine</a><sup>#</sup></li>
<li><a href="Vindesine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vindesine" title="Vindesine">Vindesine</a></li>
<li>Vinflunine<sup>§</sup></li>
<li><a href="Vinorelbine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vinorelbine" title="Vinorelbine">Vinorelbine</a><sup>#</sup>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Block microtubule disassembly</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Taxanes</i> (Cabazitaxel</li>
<li><a href="Docetaxel.htm" tppabs="https://ptable.com/wiki/compounds/A/Docetaxel" title="Docetaxel">Docetaxel</a><sup>#</sup></li>
<li>Larotaxel</li>
<li>Ortataxel<sup>†</sup></li>
<li><a href="Paclitaxel.htm" tppabs="https://ptable.com/wiki/compounds/A/Paclitaxel" title="Paclitaxel">Paclitaxel</a><sup>#</sup></li>
<li>Tesetaxel)</li>
<li><i>Epothilones</i> (Ixabepilone)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">DNA replication<br>inhibitor</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">DNA precursors/<br>antimetabolites<br>(S phase)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Folic acid</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Dihydrofolate reductase inhibitor</i> (<a href="Aminopterin.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminopterin" title="Aminopterin">Aminopterin</a></li>
<li><a href="Methotrexate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methotrexate" title="Methotrexate">Methotrexate</a><sup>#</sup></li>
<li><a href="Pemetrexed.htm" tppabs="https://ptable.com/wiki/compounds/A/Pemetrexed" title="Pemetrexed">Pemetrexed</a></li>
<li>Pralatrexate)</li>
<li><i>Thymidylate synthase inhibitor</i> (<a href="Pemetrexed.htm" tppabs="https://ptable.com/wiki/compounds/A/Pemetrexed" title="Pemetrexed">Pemetrexed</a></li>
<li><a href="Raltitrexed.htm" tppabs="https://ptable.com/wiki/compounds/A/Raltitrexed" title="Raltitrexed">Raltitrexed</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Purine</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Adenosine deaminase inhibitor</i> (<a href="Pentostatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentostatin" title="Pentostatin">Pentostatin</a>)</li></ul>

<ul><li><i>Halogenated/ribonucleotide reductase inhibitors</i> (<a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Cladribine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Cladribine'" tppabs="https://ptable.com/wiki/compounds/A/Cladribine" title="Cladribine">Cladribine</a></li>
<li><a href="Clofarabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clofarabine" title="Clofarabine">Clofarabine</a></li>
<li><a href="Fludarabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fludarabine" title="Fludarabine">Fludarabine</a>)</li>
<li><a href="Nelarabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nelarabine" title="Nelarabine">Nelarabine</a></li></ul>

<ul><li><i>Thiopurine</i> (<a href="Mercaptopurine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mercaptopurine" title="Mercaptopurine">Mercaptopurine</a><sup>#</sup></li>
<li><a href="Tioguanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tioguanine" title="Tioguanine">Tioguanine</a><sup>#</sup>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Pyrimidine</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Thymidylate synthase inhibitor</i> (<a href="Capecitabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Capecitabine" title="Capecitabine">Capecitabine</a><sup>#</sup></li>
<li><a href="Carmofur.htm" tppabs="https://ptable.com/wiki/compounds/A/Carmofur" title="Carmofur">Carmofur</a></li>
<li>Doxifluridine</li>
<li><a href="Floxuridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Floxuridine" title="Floxuridine">Floxuridine</a></li>
<li><a href="Fluorouracil.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluorouracil" title="Fluorouracil">Fluorouracil</a><sup>#</sup></li>
<li><a href="Tegafur.htm" tppabs="https://ptable.com/wiki/compounds/A/Tegafur" title="Tegafur">Tegafur</a> (+gimeracil/oteracil))</li></ul>

<ul><li><i>DNA polymerase inhibitor</i> (<a href="Cytarabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cytarabine" title="Cytarabine">Cytarabine</a><sup>#</sup>)</li></ul>

<ul><li><i>Ribonucleotide reductase inhibitor</i> (<a href="Gemcitabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Gemcitabine" title="Gemcitabine">Gemcitabine</a><sup>#</sup>)</li></ul>

<ul><li><i>Hypomethylating agent</i> (<a href="Azacitidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Azacitidine" title="Azacitidine">Azacitidine</a></li>
<li>Decitabine)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Deoxyribonucleotide</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Ribonucleotide reductase inhibitor</i> (<a href="Hydroxycarbamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroxycarbamide" title="Hydroxycarbamide">Hydroxycarbamide</a><sup>#</sup>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Topoisomerase inhibitors<br>(S phase)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">I</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Camptotheca</i> (Belotecan</li>
<li><a href="Camptothecin.htm" tppabs="https://ptable.com/wiki/compounds/A/Camptothecin" title="Camptothecin">Camptothecin</a></li>
<li><span class="new">Cositecan</span><sup>†</sup></li>
<li>Exatecan</li>
<li><span class="new">Gimatecan</span></li>
<li><a href="Irinotecan.htm" tppabs="https://ptable.com/wiki/compounds/A/Irinotecan" title="Irinotecan">Irinotecan</a><sup>#</sup></li>
<li>Lurtotecan<sup>‡</sup></li>
<li>Rubitecan<sup>‡</sup></li>
<li><span class="new">Silatecan</span><sup>§</sup></li>
<li>Topotecan)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">II</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Podophyllum</i> (<a href="Etoposide.htm" tppabs="https://ptable.com/wiki/compounds/A/Etoposide" title="Etoposide">Etoposide</a><sup>#</sup></li>
<li><a href="Teniposide.htm" tppabs="https://ptable.com/wiki/compounds/A/Teniposide" title="Teniposide">Teniposide</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">II+Intercalation</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Anthracyclines</i> (Aclarubicin</li>
<li>Amrubicin<sup>†</sup></li>
<li><a href="Daunorubicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Daunorubicin" title="Daunorubicin">Daunorubicin</a><sup>#</sup></li>
<li><a href="Doxorubicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxorubicin" title="Doxorubicin">Doxorubicin</a><sup>#</sup></li>
<li><a href="Epirubicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Epirubicin" title="Epirubicin">Epirubicin</a></li>
<li><a href="Idarubicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Idarubicin" title="Idarubicin">Idarubicin</a></li>
<li><a href="Pirarubicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pirarubicin" title="Pirarubicin">Pirarubicin</a></li>
<li><a href="Valrubicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Valrubicin" title="Valrubicin">Valrubicin</a></li>
<li>Zorubicin)</li>
<li><i><a href="Anthraquinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Anthraquinone" title="Anthraquinone">Anthracenediones</a></i> (<a href="Mitoxantrone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mitoxantrone" title="Mitoxantrone">Mitoxantrone</a></li>
<li>Pixantrone)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Crosslinking of DNA<br>(CCNS)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Alkylating</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Nitrogen mustards:</i> Bendamustine<sup>#</sup></li>
<li>Chlormethine</li>
<li><a href="Cyclophosphamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclophosphamide" title="Cyclophosphamide">Cyclophosphamide</a><sup>#</sup> (<a href="Ifosfamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Ifosfamide" title="Ifosfamide">Ifosfamide</a><sup>#</sup></li>
<li>Trofosfamide)</li>
<li><a href="Chlorambucil.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorambucil" title="Chlorambucil">Chlorambucil</a><sup>#</sup> (<a href="Melphalan.htm" tppabs="https://ptable.com/wiki/compounds/A/Melphalan" title="Melphalan">Melphalan</a></li>
<li><a href="Prednimustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prednimustine" title="Prednimustine">Prednimustine</a>)</li>
<li><a href="Uramustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Uramustine" title="Uramustine">Uramustine</a></li></ul>

<ul><li><i>Nitrosoureas:</i> <a href="Carmustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carmustine" title="Carmustine">Carmustine</a></li>
<li><a href="Fotemustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fotemustine" title="Fotemustine">Fotemustine</a></li>
<li><a href="Lomustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lomustine" title="Lomustine">Lomustine</a> (<a href="Semustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Semustine" title="Semustine">Semustine</a>)</li>
<li>Nimustine</li>
<li>Ranimustine</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Streptozotocin  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Streptozotocin'" tppabs="https://ptable.com/wiki/compounds/A/Streptozotocin" title="Streptozotocin">Streptozocin</a></li></ul>

<ul><li><i>Alkyl sulfonates:</i> <a href="Busulfan.htm" tppabs="https://ptable.com/wiki/compounds/A/Busulfan" title="Busulfan">Busulfan</a> (Mannosulfan</li>
<li><a href="Treosulfan.htm" tppabs="https://ptable.com/wiki/compounds/A/Treosulfan" title="Treosulfan">Treosulfan</a>)</li></ul>

<ul><li><i><a href="Aziridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Aziridine" title="Aziridine">Aziridines</a>:</i> Carboquone</li>
<li>Thiotepa</li>
<li><a href="Triaziquone.htm" tppabs="https://ptable.com/wiki/compounds/A/Triaziquone" title="Triaziquone">Triaziquone</a></li>
<li><a href="Triethylenemelamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Triethylenemelamine" title="Triethylenemelamine">Triethylenemelamine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Platinum-based</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Carboplatin  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Carboplatin'" tppabs="https://ptable.com/wiki/compounds/A/Carboplatin" title="Carboplatin">Carboplatin</a><sup>#</sup></li>
<li><a href="Cisplatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cisplatin" title="Cisplatin">Cisplatin</a><sup>#</sup></li>
<li>Dicycloplatin</li>
<li>Nedaplatin</li>
<li><a href="Oxaliplatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxaliplatin" title="Oxaliplatin">Oxaliplatin</a><sup>#</sup></li>
<li>Satraplatin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Nonclassical</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Altretamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Altretamine" title="Altretamine">Altretamine</a></li>
<li><i><a href="Hydrazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrazine" title="Hydrazine">Hydrazines</a></i> (<a href="Procarbazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Procarbazine" title="Procarbazine">Procarbazine</a><sup>#</sup>)</li>
<li><a href="Mitobronitol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mitobronitol" title="Mitobronitol">Mitobronitol</a></li>
<li><a href="Pipobroman.htm" tppabs="https://ptable.com/wiki/compounds/A/Pipobroman" title="Pipobroman">Pipobroman</a></li>
<li><i>Triazenes</i> (<a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Dacarbazine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Dacarbazine'" tppabs="https://ptable.com/wiki/compounds/A/Dacarbazine" title="Dacarbazine">Dacarbazine</a><sup>#</sup></li>
<li><a href="Temozolomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Temozolomide" title="Temozolomide">Temozolomide</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Intercalation</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Streptomyces (<a href="Actinomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Actinomycin" title="Actinomycin" class="mw-redirect">Actinomycin</a><sup>#</sup></li>
<li><a href="Bleomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bleomycin" title="Bleomycin">Bleomycin</a><sup>#</sup></li>
<li>Mitomycins</li>
<li><a href="Plicamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Plicamycin" title="Plicamycin">Plicamycin</a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Photosensitizers/PDT</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Aminolevulinic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminolevulinic_acid" title="Aminolevulinic acid">Aminolevulinic acid</a><span>&nbsp;</span>/ <a href="Methyl_aminolevulinate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyl_aminolevulinate" title="Methyl aminolevulinate">Methyl aminolevulinate</a></li>
<li>Efaproxiral</li>
<li>Padeliporfin</li>
<li><i><a href="Porphyrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Porphyrin" title="Porphyrin">Porphyrin derivatives</a></i> (<a href="Porfimer_sodium.htm" tppabs="https://ptable.com/wiki/compounds/A/Porfimer_sodium" title="Porfimer sodium">Porfimer sodium</a></li>
<li>Talaporfin</li>
<li>Temoporfin</li>
<li><a href="Verteporfin.htm" tppabs="https://ptable.com/wiki/compounds/A/Verteporfin" title="Verteporfin">Verteporfin</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Enzyme inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>FI</i> (Tipifarnib<sup>§</sup>)</li>
<li><i>CDK inhibitors</i> (Abemaciclib</li>
<li>Alvocidib<sup>†</sup></li>
<li>Palbociclib</li>
<li>Ribociclib</li>
<li>Seliciclib<sup>†</sup>)</li>
<li><i>PrI</i>
<ul><li><a href="Bortezomib.htm" tppabs="https://ptable.com/wiki/compounds/A/Bortezomib" title="Bortezomib">Bortezomib</a></li>
<li>Carfilzomib</li>
<li>Ixazomib</li></ul></li>
<li><i>PhI</i> (<a href="Anagrelide.htm" tppabs="https://ptable.com/wiki/compounds/A/Anagrelide" title="Anagrelide">Anagrelide</a>)</li>
<li><i>IMPDI</i> (Tiazofurin<sup>§</sup>)</li>
<li><i>LI</i> (<a href="Masoprocol.htm" tppabs="https://ptable.com/wiki/compounds/A/Masoprocol" title="Masoprocol">Masoprocol</a>)</li>
<li><i>PARP inhibitor</i> (Niraparib</li>
<li>Olaparib</li>
<li>Rucaparib)</li>
<li><i>HDAC</i> (Belinostat</li>
<li>Panobinostat</li>
<li>Romidepsin</li>
<li><a href="Vorinostat.htm" tppabs="https://ptable.com/wiki/compounds/A/Vorinostat" title="Vorinostat">Vorinostat</a>)</li>
<li><i>PIKI</i> (Alpelisib</li>
<li>Idelalisib)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Receptor antagonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>ERA</i> (Atrasentan)</li>
<li><i>Retinoid X receptor</i> (<a href="Bexarotene.htm" tppabs="https://ptable.com/wiki/compounds/A/Bexarotene" title="Bexarotene">Bexarotene</a>)</li>
<li><i>Sex steroid</i> (<a href="Testolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testolactone" title="Testolactone">Testolactone</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other/ungrouped</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amsacrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amsacrine" title="Amsacrine">Amsacrine</a></li>
<li><a href="Arsenic_trioxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Arsenic_trioxide" title="Arsenic trioxide">Arsenic trioxide</a></li>
<li><i><a href="Asparagine.htm" tppabs="https://ptable.com/wiki/compounds/A/Asparagine" title="Asparagine">Asparagine depleters</a></i> (<a href="Asparaginase.htm" tppabs="https://ptable.com/wiki/compounds/A/Asparaginase" title="Asparaginase">Asparaginase</a><sup>#</sup>/<a href="Pegaspargase.htm" tppabs="https://ptable.com/wiki/compounds/A/Pegaspargase" title="Pegaspargase">Pegaspargase</a>)</li>
<li><a href="Celecoxib.htm" tppabs="https://ptable.com/wiki/compounds/A/Celecoxib" title="Celecoxib">Celecoxib</a></li>
<li><a href="Demecolcine.htm" tppabs="https://ptable.com/wiki/compounds/A/Demecolcine" title="Demecolcine">Demecolcine</a></li>
<li>Elesclomol<sup>§</sup></li>
<li>Elsamitrucin</li>
<li>Eribulin</li>
<li>Estramustine phosphate</li>
<li><a href="Etoglucid.htm" tppabs="https://ptable.com/wiki/compounds/A/Etoglucid" title="Etoglucid">Etoglucid</a></li>
<li><a href="Lonidamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lonidamine" title="Lonidamine">Lonidamine</a></li>
<li>Lucanthone</li>
<li>Mitoguazone</li>
<li><a href="Mitotane.htm" tppabs="https://ptable.com/wiki/compounds/A/Mitotane" title="Mitotane">Mitotane</a></li>
<li>Oblimersen<sup>†</sup></li>
<li>Omacetaxine mepesuccinate</li>
<li>Trabectedin</li>
<li><i>Retinoids</i> (<a href="Alitretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Alitretinoin" title="Alitretinoin">Alitretinoin</a></li>
<li><a href="Tretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tretinoin" title="Tretinoin">Tretinoin</a><sup>#</sup>)</li>
<li>Venetoclax</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Xenobiotic-sensing_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Xenobiotic-sensing_receptor_modulators" style="font-size:114%;margin:0 4em">Xenobiotic-sensing receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>CAR</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">6,7-Dimethylesculetin</span></li>
<li><a href="Amiodarone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amiodarone" title="Amiodarone">Amiodarone</a></li>
<li><a href="Artemisinin.htm" tppabs="https://ptable.com/wiki/compounds/A/Artemisinin" title="Artemisinin">Artemisinin</a></li>
<li><span class="new">Benfuracarb</span></li>
<li><a href="Carbamazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbamazepine" title="Carbamazepine">Carbamazepine</a></li>
<li><a href="Carvedilol.htm" tppabs="https://ptable.com/wiki/compounds/A/Carvedilol" title="Carvedilol">Carvedilol</a></li>
<li><a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li><a href="Chrysin.htm" tppabs="https://ptable.com/wiki/compounds/A/Chrysin" title="Chrysin">Chrysin</a></li>
<li><span class="new">CITCO</span></li>
<li><a href="Clotrimazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Clotrimazole" title="Clotrimazole">Clotrimazole</a></li>
<li><a href="Cyclophosphamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclophosphamide" title="Cyclophosphamide">Cyclophosphamide</a></li>
<li><a href="Cypermethrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cypermethrin" title="Cypermethrin">Cypermethrin</a></li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA</a> (prasterone)</li>
<li><a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">Efavirenz</a></li>
<li><a href="Ellagic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Ellagic_acid" title="Ellagic acid">Ellagic acid</a></li>
<li><a href="Griseofulvin.htm" tppabs="https://ptable.com/wiki/compounds/A/Griseofulvin" title="Griseofulvin">Griseofulvin</a></li>
<li><a href="Methoxychlor.htm" tppabs="https://ptable.com/wiki/compounds/A/Methoxychlor" title="Methoxychlor">Methoxychlor</a></li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li>
<li><a href="Nefazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nefazodone" title="Nefazodone">Nefazodone</a></li>
<li><a href="Nevirapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nevirapine" title="Nevirapine">Nevirapine</a></li>
<li><a href="Nicardipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicardipine" title="Nicardipine">Nicardipine</a></li>
<li><span class="new">Octicizer</span></li>
<li><a href="Permethrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Permethrin" title="Permethrin">Permethrin</a></li>
<li><a href="Phenobarbital.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenobarbital" title="Phenobarbital">Phenobarbital</a></li>
<li><a href="Phenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenytoin" title="Phenytoin">Phenytoin</a></li>
<li>Pregnanedione (5β-dihydroprogesterone)</li>
<li><a href="Reserpine.htm" tppabs="https://ptable.com/wiki/compounds/A/Reserpine" title="Reserpine">Reserpine</a></li>
<li><span class="new">TCPOBOP</span></li>
<li><a href="Telmisartan.htm" tppabs="https://ptable.com/wiki/compounds/A/Telmisartan" title="Telmisartan">Telmisartan</a></li>
<li><a href="Tolnaftate.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolnaftate" title="Tolnaftate">Tolnaftate</a></li>
<li><a href="Troglitazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Troglitazone" title="Troglitazone">Troglitazone</a></li>
<li><a href="Valproic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Valproic_acid" title="Valproic acid" class="mw-redirect">Valproic acid</a></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">3,17β-Estradiol</span></li>
<li><span class="new">3α-Androstanol</span></li>
<li>3α-Androstenol</li>
<li><span class="new">3β-Androstanol</span></li>
<li><span class="new">17-Androstanol</span></li>
<li><a href="Allyl_isothiocyanate.htm" tppabs="https://ptable.com/wiki/compounds/A/Allyl_isothiocyanate" title="Allyl isothiocyanate">AITC</a></li>
<li>Ethinylestradiol</li>
<li>Meclizine</li>
<li><span class="new">Nigramide J</span></li>
<li><a href="Okadaic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Okadaic_acid" title="Okadaic acid">Okadaic acid</a></li>
<li>PK-11195</li>
<li><span class="new">S-07662</span></li>
<li><span class="new">T-0901317</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>PXR</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> 17α-Hydroxypregnenolone</li>
<li>17α-Hydroxyprogesterone</li>
<li><a href="Androstenedione.htm" tppabs="https://ptable.com/wiki/compounds/A/%CE%944-Androstenedione" title="Δ4-Androstenedione" class="mw-redirect">Δ<sup>4</sup>-Androstenedione</a></li>
<li><a href="Androstenediol.htm" tppabs="https://ptable.com/wiki/compounds/A/%CE%945-Androstenediol" title="Δ5-Androstenediol" class="mw-redirect">Δ<sup>5</sup>-Androstenediol</a></li>
<li>Δ<sup>5</sup>-Androstenedione</li>
<li><span class="new">AA-861</span></li>
<li>Allopregnanediol</li>
<li><a href="5α-Dihydroprogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/5%CE%B1-Dihydroprogesterone" title="5α-Dihydroprogesterone">Allopregnanedione (5α-dihydroprogesterone)</a></li>
<li><a href="Allopregnanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Allopregnanolone" title="Allopregnanolone">Allopregnanolone (brexanolone)</a></li>
<li>Alpha-Lipoic acid</li>
<li>Ambrisentan</li>
<li>AMI-193</li>
<li>Amlodipine besylate</li>
<li>Antimycotics</li>
<li><a href="Artemisinin.htm" tppabs="https://ptable.com/wiki/compounds/A/Artemisinin" title="Artemisinin">Artemisinin</a></li>
<li><a href="Aurothioglucose.htm" tppabs="https://ptable.com/wiki/compounds/A/Aurothioglucose" title="Aurothioglucose">Aurothioglucose</a></li>
<li>Bile acids</li>
<li><a href="Bithionol.htm" tppabs="https://ptable.com/wiki/compounds/A/Bithionol" title="Bithionol">Bithionol</a></li>
<li><a href="Bosentan.htm" tppabs="https://ptable.com/wiki/compounds/A/Bosentan" title="Bosentan">Bosentan</a></li>
<li><span class="new">Bumecaine</span></li>
<li>Cafestol</li>
<li><a href="Cephaloridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cephaloridine" title="Cephaloridine">Cephaloridine</a></li>
<li><a href="Cefradine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cephradine" title="Cephradine" class="mw-redirect">Cephradine</a></li>
<li><a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li>Ciglitazone</li>
<li><a href="Clindamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Clindamycin" title="Clindamycin">Clindamycin</a></li>
<li>Clofenvinfos</li>
<li><a href="Chloroxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chloroxine" title="Chloroxine">Chloroxine</a></li>
<li><a href="Clotrimazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Clotrimazole" title="Clotrimazole">Clotrimazole</a></li>
<li><a href="Colforsin.htm" tppabs="https://ptable.com/wiki/compounds/A/Colforsin" title="Colforsin">Colforsin</a></li>
<li><a href="Corticosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Corticosterone" title="Corticosterone">Corticosterone</a></li>
<li><a href="Cyclophosphamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclophosphamide" title="Cyclophosphamide">Cyclophosphamide</a></li>
<li>Cyproterone acetate</li>
<li><a href="Demecolcine.htm" tppabs="https://ptable.com/wiki/compounds/A/Demecolcine" title="Demecolcine">Demecolcine</a></li>
<li><a href="Dexamethasone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexamethasone" title="Dexamethasone">Dexamethasone</a></li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA</a> (prasterone)</li>
<li><a href="Dehydroepiandrosterone_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone_sulfate" title="Dehydroepiandrosterone sulfate">DHEA-S</a> (prasterone sulfate)</li>
<li>Dibunate sodium</li>
<li>Diclazuril</li>
<li><a href="Dicloxacillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Dicloxacillin" title="Dicloxacillin">Dicloxacillin</a></li>
<li><a href="Dimercaprol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimercaprol" title="Dimercaprol">Dimercaprol</a></li>
<li><span class="new">Dinaline</span></li>
<li><a href="Docetaxel.htm" tppabs="https://ptable.com/wiki/compounds/A/Docetaxel" title="Docetaxel">Docetaxel</a></li>
<li>Docusate calcium</li>
<li>Dodecylbenzenesulfonic acid</li>
<li>Dronabinol</li>
<li>Droxidopa</li>
<li><a href="Vinburnine.htm" tppabs="https://ptable.com/wiki/compounds/A/Eburnamonine" title="Eburnamonine" class="mw-redirect">Eburnamonine</a></li>
<li>Ecopipam</li>
<li>Enzacamene</li>
<li>Epothilone B</li>
<li><a href="Erythromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Erythromycin" title="Erythromycin">Erythromycin</a></li>
<li>Famprofazone</li>
<li><span class="new">Febantel</span></li>
<li><a href="Felodipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Felodipine" title="Felodipine">Felodipine</a></li>
<li><a href="Fenbendazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenbendazole" title="Fenbendazole">Fenbendazole</a></li>
<li><a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li><a href="Flucloxacillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Flucloxacillin" title="Flucloxacillin">Flucloxacillin</a></li>
<li><a href="Fluorometholone.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluorometholone" title="Fluorometholone">Fluorometholone</a></li>
<li><a href="Griseofulvin.htm" tppabs="https://ptable.com/wiki/compounds/A/Griseofulvin" title="Griseofulvin">Griseofulvin</a></li>
<li>Guggulsterone</li>
<li><a href="Haloprogin.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloprogin" title="Haloprogin">Haloprogin</a></li>
<li>Hetacillin potassium</li>
<li><a href="Hyperforin.htm" tppabs="https://ptable.com/wiki/compounds/A/Hyperforin" title="Hyperforin">Hyperforin</a></li>
<li><i>Hypericum perforatum</i> (St John's wort)</li>
<li>Indinavir sulfate</li>
<li>Lasalocid sodium</li>
<li><a href="Levothyroxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Levothyroxine" title="Levothyroxine">Levothyroxine</a></li>
<li><a href="Linolenic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Linolenic_acid" title="Linolenic acid">Linolenic acid</a></li>
<li><span class="new">LOE-908</span></li>
<li><a href="Loratadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loratadine" title="Loratadine">Loratadine</a></li>
<li><a href="Lovastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Lovastatin" title="Lovastatin">Lovastatin</a></li>
<li>Meclizine</li>
<li><a href="Metacycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Metacycline" title="Metacycline">Metacycline</a></li>
<li><a href="Methylprednisolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylprednisolone" title="Methylprednisolone">Methylprednisolone</a></li>
<li><a href="Metyrapone.htm" tppabs="https://ptable.com/wiki/compounds/A/Metyrapone" title="Metyrapone">Metyrapone</a></li>
<li><a href="Mevastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mevastatin" title="Mevastatin">Mevastatin</a></li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li>
<li><a href="Nafcillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Nafcillin" title="Nafcillin">Nafcillin</a></li>
<li><a href="Nicardipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicardipine" title="Nicardipine">Nicardipine</a></li>
<li><a href="Nicotine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotine" title="Nicotine">Nicotine</a></li>
<li><a href="Nifedipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nifedipine" title="Nifedipine">Nifedipine</a></li>
<li>Nilvadipine</li>
<li><a href="Nisoldipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nisoldipine" title="Nisoldipine">Nisoldipine</a></li>
<li>Norelgestromin</li>
<li><a href="Omeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Omeprazole" title="Omeprazole">Omeprazole</a></li>
<li><a href="Orlistat.htm" tppabs="https://ptable.com/wiki/compounds/A/Orlistat" title="Orlistat">Orlistat</a></li>
<li><a href="Oxatomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxatomide" title="Oxatomide">Oxatomide</a></li>
<li><a href="Paclitaxel.htm" tppabs="https://ptable.com/wiki/compounds/A/Paclitaxel" title="Paclitaxel">Paclitaxel</a></li>
<li><a href="Phenobarbital.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenobarbital" title="Phenobarbital">Phenobarbital</a></li>
<li><a href="Piperine.htm" tppabs="https://ptable.com/wiki/compounds/A/Piperine" title="Piperine">Piperine</a></li>
<li><a href="Plicamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Plicamycin" title="Plicamycin">Plicamycin</a></li>
<li><a href="Prednisolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Prednisolone" title="Prednisolone">Prednisolone</a></li>
<li><a href="Pregnanediol.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregnanediol" title="Pregnanediol">Pregnanediol</a></li>
<li>Pregnanedione (5β-dihydroprogesterone)</li>
<li>Pregnanolone</li>
<li><a href="Pregnenolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregnenolone" title="Pregnenolone">Pregnenolone</a></li>
<li>Pregnenolone 16α-carbonitrile</li>
<li>Proadifen</li>
<li><a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">Progesterone</a></li>
<li>Quingestrone</li>
<li><a href="Reserpine.htm" tppabs="https://ptable.com/wiki/compounds/A/Reserpine" title="Reserpine">Reserpine</a></li>
<li>Reverse triiodothyronine</li>
<li><a href="Rifampicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rifampicin" title="Rifampicin">Rifampicin</a></li>
<li><a href="Rifaximin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rifaximin" title="Rifaximin">Rifaximin</a></li>
<li><a href="Rimexolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Rimexolone" title="Rimexolone">Rimexolone</a></li>
<li>Riodipine</li>
<li><a href="Ritonavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ritonavir" title="Ritonavir">Ritonavir</a></li>
<li><a href="Simvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Simvastatin" title="Simvastatin">Simvastatin</a></li>
<li><a href="Sirolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Sirolimus" title="Sirolimus">Sirolimus</a></li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li>
<li>Spiroxatrine</li>
<li><span class="new">SR-12813</span></li>
<li><span class="new">Suberoylanilide</span></li>
<li>Sulfisoxazole</li>
<li><a href="Suramin.htm" tppabs="https://ptable.com/wiki/compounds/A/Suramin" title="Suramin">Suramin</a></li>
<li><a href="Tacrolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrolimus" title="Tacrolimus">Tacrolimus</a></li>
<li><span class="new">Tenylidone</span></li>
<li><a href="Terconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Terconazole" title="Terconazole">Terconazole</a></li>
<li>Testosterone isocaproate</li>
<li><a href="Tetracycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetracycline" title="Tetracycline">Tetracycline</a></li>
<li>Thiamylal sodium</li>
<li><a href="Thiothixene.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiothixene" title="Thiothixene" class="mw-redirect">Thiothixene</a></li>
<li>Thonzonium bromide</li>
<li>Tianeptine</li>
<li><a href="Troglitazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Troglitazone" title="Troglitazone">Troglitazone</a></li>
<li><a href="Troleandomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Troleandomycin" title="Troleandomycin">Troleandomycin</a></li>
<li><span class="new">Tropanyl 3,5-dimethulbenzoate</span></li>
<li><a href="Zafirlukast.htm" tppabs="https://ptable.com/wiki/compounds/A/Zafirlukast" title="Zafirlukast">Zafirlukast</a></li>
<li><a href="Zeranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Zeranol" title="Zeranol">Zeranol</a></li></ul>

<ul><li><i>Antagonists:</i> <a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li><a href="Sesamin.htm" tppabs="https://ptable.com/wiki/compounds/A/Sesamin" title="Sesamin">Sesamin</a></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd><i>Receptor/signaling modulators</i></dd></dl>
</div></td></tr></tbody></table></div><span>
</span>












<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-07-30" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Cyclophosphamide&oldid=970230891  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Cyclophosphamide&oldid=970230891'" tppabs="https://en.wikipedia.org/wiki/?title=Cyclophosphamide&oldid=970230891">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>